This inventor holds 5 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Zealand Pharma A/s, Wyeth. Active years: 2006-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 94 
3 out of 1,309 
Years Active: 2006-2013
Title: Edward Harvel Kerns: Innovator in Pharmacological Compounds
Introduction
Edward Harvel Kerns is a notable inventor based in Skillman, NJ (US). He has made significant contributions to the field of pharmacology, particularly through his innovative work on lysine-mimetic compounds. With a total of 5 patents, Kerns has established himself as a key figure in the development of compounds with useful pharmacological activity.
Latest Patents
Kerns' latest patents focus on modified lysine-mimetic compounds. These compounds exhibit useful pharmacological activity, including antiarrhythmic properties and desirable bioavailability characteristics. His work in this area has the potential to impact various therapeutic applications significantly.
Career Highlights
Throughout his career, Kerns has worked with prominent companies in the pharmaceutical industry, including Zealand Pharma A/S and Wyeth. His experience in these organizations has allowed him to collaborate with other experts and contribute to groundbreaking research in pharmacology.
Collaborations
Some of Kerns' notable coworkers include Bjarne Due Larsen and Jørgen Søberg Petersen. Their collaborative efforts have further advanced the research and development of innovative pharmacological solutions.
Conclusion
Edward Harvel Kerns is a distinguished inventor whose work on lysine-mimetic compounds has made a significant impact in the field of pharmacology. His contributions continue to influence the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile